Pfizer (PFE) reported Q3 FY 2020 earnings of $0.72 per share (versus $0.75 per share in Q3 FY 2019), beating analysts’ consensus estimate of $0.71 per share.
The company’s quarterly revenues amounted to $12.131 bln (-4.3% y/y), missing analysts’ consensus estimate of $12.298 bln.
PFE fell to $37.86 (-0.16%) in pre-market trading.